.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
McKesson
McKinsey
Healthtrust
Cipla
Daiichi Sankyo
Argus Health
US Department of Justice
Farmers Insurance
Express Scripts

Generated: June 27, 2017

DrugPatentWatch Database Preview

LATANOPROST Drug Profile

« Back to Dashboard

Which patents cover Latanoprost, and when can generic versions of Latanoprost launch?

Latanoprost is a drug marketed by Bausch And Lomb, Amring Pharms, Fdc Ltd, Sandoz Inc, Dr Reddys Labs Ltd, Mylan, Akorn, and Apotex Inc. and is included in eight NDAs.

The generic ingredient in LATANOPROST is latanoprost. There are nineteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the latanoprost profile page.

Summary for Tradename: LATANOPROST

Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: see list11
Bulk Api Vendors: see list35
Clinical Trials: see list140
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LATANOPROST at DailyMed

Pharmacology for Tradename: LATANOPROST

Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC201006-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe
Akorn
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC090887-001Jul 19, 2011ATRXNoNo► Subscribe► Subscribe
Sandoz Inc
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC091449-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe
Apotex Inc
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC077697-001Mar 22, 2011DISCNNoNo► Subscribe► Subscribe
Amring Pharms
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC200925-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Cantor Fitzgerald
US Army
UBS
Deloitte
Fish and Richardson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot